In addition to the reduction in CrC, our data reproduced the kinetics of both early and late biochemical indicators of CKD MBD; early biochemical markers included a rise in FeP and FGF-23 levels, with elevation of PTH levels and hyperphosphatemia as late markers. This evidence concerns the gene PTH and Marchiafava-Bignami disease.